| | BRCA2, LOC106721785 +1 more | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | BRCA2, LOC106721785 +1 more | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | LOC106721785, ZAR1L +1 more | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant | not provided +3 more | |
| | | Deletion | Hereditary breast ovarian cancer syndrome | |
| | BRCA2, LOC106721785 +1 more | Deletion | Hereditary breast ovarian cancer syndrome | |
| | BRCA2, LOC106721785 +1 more | Deletion | Hereditary breast ovarian cancer syndrome | |
| | BRCA2, LOC106721785 +3 more | Deletion | Hereditary breast ovarian cancer syndrome | |
| | BRCA2, LOC106721785 +1 more | Deletion | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | not provided +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Insertion (5 prime UTR variant +1 more) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Deletion (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Hereditary breast ovarian cancer syndrome | |
| | | Insertion (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | not provided +1 more | |
| | | Deletion (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | not specified +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant) | not specified +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Deletion (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Deletion (splice donor variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome +1 more | |
| | | Single nucleotide variant (splice donor variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (splice donor variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (splice donor variant) | Hereditary breast ovarian cancer syndrome +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (splice donor variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (splice donor variant) | Fanconi anemia complementation group D1 +2 more | GConflicting classifications of pathogenicity |
| | | Deletion (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Microsatellite (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Microsatellite (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome +1 more | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome +1 more | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |